全球诊断市场中的人工智慧:趋势、机会和竞争分析 [2023-2028]
市场调查报告书
商品编码
1342023

全球诊断市场中的人工智慧:趋势、机会和竞争分析 [2023-2028]

Artificial Intelligence in the Global Diagnostic Market: Trends, Opportunities and Competitive Analysis [2023-2028]

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

诊断市场的人工智慧趋势和预测

人工智慧在全球诊断市场的未来性广阔,放射学、肿瘤学、神经病学和心臟病学、胸肺病学和病理学市场都有商机。到 2028 年,全球诊断市场中人工智慧的使用预计将达到 38 亿美元,2023 年至 2028 年的年复合成长率为 33.5%。该市场的主要促进因素是降低诊断成本的需求不断增长、医疗保健领域的技术开拓以及对低成本诊断组件的需求不断增加。

诊断市场的人工智慧洞察

  • Lucintel 预测人工智慧驱动的软体将取得进步,该软体专为实验室精确的医疗保健诊断而设计,以及支援人工智慧和以云端为中心的增强诊断,可在解释患者医学影像的同时显着提高诊断准确性。软体预计将在预测期间实现最高增长由于对解决方案的需求不断增加。
  • 由于神经系统疾病罹患率不断上升,以及世界各地在神经系统疾病病例的治疗中采用基于价值的护理的趋势不断增长,神经病学和心臟病学将继续成为最大的细分市场。
  • 由于电子健康记录(EHR)、远端医疗服务、其他数位医疗解决方案以及人工智慧主导诊断设备的无缝整合的普及,北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题:

  • Q1.诊断市场中的人工智慧依组成部分(硬体、软体、服务)、技术(机器学习、NLP、情境计算、电脑视觉)和诊断类型(放射学、肿瘤学、神经学)和心臟病学、胸肺学、病理学、其他)以及按地区(北美、欧洲、亚太地区、世界其他地区)划分,哪些最有前途且具有最高的成长机会?
  • Q.2. 未来哪个细分市场成长较快?为什么?
  • Q.3.您认为哪个地区成长较快,为什么?
  • Q.4. 影响市场动态的主要要素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?此外,主要企业正在采取什么样的策略配合措施?
  • Q10.该市场的竞争产品有哪些?因材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球诊断市场中的人工智慧:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2017-2028年市场趋势及预测分析

  • 宏观经济趋势(2017-2022)与预测(2023-2028)
  • 全球诊断市场的人工智慧趋势(2017-2022)和预测(2023-2028)
  • 按组件分類的全球诊断市场中的人工智慧
    • 硬体
    • 软体
    • 服务
  • 全球诊断市场人工智慧技术分析
    • 机器学习
    • NLP
    • 上下文感知计算
    • 电脑视觉
  • 按诊断类型分類的全球诊断市场中的人工智慧
    • 放射科
    • 肿瘤学
    • 神经病学和循环系统医学
    • 胸部和肺部
    • 病理
    • 其他的

第4章2017-2028年分地区市场趋势及预测分析

  • 按地区分類的全球诊断市场中的人工智慧
  • 北美诊断市场的人工智慧
  • 欧洲诊断市场的人工智慧
  • 亚太诊断市场的人工智慧
  • 其他区域诊断市场的人工智慧

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球诊断市场中人工智慧的成长机会(按组成部分)
    • 按技术分類的全球诊断市场人工智慧的成长机会
    • 按诊断类型分類的全球诊断市场人工智慧的成长机会
    • 全球诊断市场人工智慧成长机会(按地区)
  • 全球诊断市场人工智慧新趋势
  • 战略分析
    • 新产品开发
    • 扩大人工智慧在全球诊断市场的能力
    • 全球诊断市场的人工智慧合併和收购企业
    • 认证和许可

第7章主要企业概况

  • General Electric
  • Siemens
  • Aidoc Medical
  • AliveCor
  • Imagen Technologies
  • VUNO
  • IDx Technologies
  • NovaSignal Corporation
  • Riverain Technologies
  • Zebra Medical Vision
简介目录

Artificial Intelligence in the Diagnostic Market Trends and Forecast

The future of artificial intelligence in the global diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets. The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 33.5% from 2023 to 2028. The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.

A more than 150-page report is developed to help in your business decisions.

Artificial Intelligence in the Diagnostic Market by Segment

The study includes trends and forecast for artificial intelligence in the global diagnostic market by component, technology, diagnosis type, and region as follows:

Artificial Intelligence in the Diagnostic Market by Component [Shipment Analysis by Value from 2017 to 2028]:

  • Hardware
  • Software
  • Services

Artificial Intelligence in the Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

  • Machine Learning
  • NLP
  • Context-Aware Computing
  • Computer Vision

Artificial Intelligence in the Diagnostic Market by Diagnosis Type [Shipment Analysis by Value from 2017 to 2028]:

  • Radiology
  • Oncology
  • Neurology & Cardiology
  • Chest & Lungs
  • Pathology
  • Others

Artificial Intelligence in the Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Artificial Intelligence Companies in the Diagnostic Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, artificial intelligence companies in the diagnostic market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of artificial intelligence companies in the diagnostic market profiled in this report include:

  • General Electric
  • Siemens
  • Aidoc Medical
  • AliveCor
  • Imagen Technologies
  • VUNO
  • IDx Technologies
  • NovaSignal Corporation
  • Riverain Technologies
  • Zebra Medical Vision

Artificial Intelligence in the Diagnostic Market Insights

  • Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
  • Neurology & cardiology will remain the largest segment due to rising incidence of neurological disorders and increasing trend of adopting value based care in treating the cases of neurological disorders across the globe.
  • North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.

Features of Artificial Intelligence in the Diagnostic Market

  • Market Size Estimates: Artificial intelligence in the diagnostic market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Artificial intelligence in the diagnostic market size by various segments, such as by component, technology, diagnosis type, and region in terms of value ($B).
  • Regional Analysis: Artificial intelligence in the diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different components, technologies, diagnosis types, and regions for artificial intelligence in the diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of artificial intelligence in the diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q1. What is artificial intelligence in the diagnostic market size?
  • Answer: The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028.
  • Q2.What is the growth forecast for artificial intelligence in the diagnostic market?
  • Answer: The use of artificial intelligence in the global diagnostic market is expected to grow with a CAGR of 33.5% from 2023 to 2028.
  • Q3.What are the major drivers influencing the growth of artificial intelligence in the diagnostic market?
  • Answer: The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.
  • Q4. What are the major segments for artificial intelligence in the diagnostic market?
  • Answer: The future of artificial intelligence in the diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets.
  • Q5. Who are the key artificial intelligence companies in the diagnostic market?
  • Answer: Some of the key artificial intelligence companies in the diagnostic market are as follows:
    • General Electric
    • Siemens
    • Aidoc Medical
    • AliveCor
    • Imagen Technologies
    • VUNO
    • IDx Technologies
    • NovaSignal Corporation
    • Riverain Technologies
    • Zebra Medical Vision
  • Q6. Which segment in the diagnostic market in terms of artificial Intelligence usage will be the largest in future?
  • Answer: Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
  • Q7. In the diagnostic market in terms of artificial Intelligence usage, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q1. What are some of the most promising, high-growth opportunities for artificial intelligence in the diagnostic market by component (hardware, software, and services), technology (machine learning, NLP, context-aware computing, computer vision), diagnosis type (radiology, oncology, neurology & cardiology, chest & lungs, pathology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Artificial Intelligence in the Global Diagnostic Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Artificial Intelligence in the Global Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Artificial Intelligence in the Global Diagnostic Market by Component
    • 3.3.1: Hardware
    • 3.3.2: Software
    • 3.3.3: Services
  • 3.4: Artificial Intelligence in the Global Diagnostic Market by Technology
    • 3.4.1: Machine Learning
    • 3.4.2: NLP
    • 3.4.3: Context-Aware Computing
    • 3.4.4: Computer Vision
  • 3.5: Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
    • 3.5.1: Radiology
    • 3.5.2: Oncology
    • 3.5.3: Neurology & Cardiology
    • 3.5.4: Chest & Lungs
    • 3.5.5: Pathology
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Artificial Intelligence in the Global Diagnostic Market by Region
  • 4.2: Artificial Intelligence in the North American Diagnostic Market
    • 4.2.1: Artificial Intelligence in the North American Diagnostic Market by Component: Hardware, Software, and Services
    • 4.2.2: Artificial Intelligence in the North American Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
  • 4.3: Artificial Intelligence in the European Diagnostic Market
    • 4.3.1: Artificial Intelligence in the European Diagnostic Market by Component: Hardware, Software, and Services
    • 4.3.2: Artificial Intelligence in the European Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
  • 4.4: Artificial Intelligence in the APAC Diagnostic Market
    • 4.4.1: Artificial Intelligence in the APAC Diagnostic Market by Component: Hardware, Software, and Services
    • 4.4.2: Artificial Intelligence in the APAC Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
  • 4.5: Artificial Intelligence in the ROW Diagnostic Market
    • 4.5.1: Artificial Intelligence in the ROW Diagnostic Market by Component: Hardware, Software, and Services
    • 4.5.2: Artificial Intelligence in the ROW Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Component
    • 6.1.2: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Technology
    • 6.1.3: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
    • 6.1.4: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Region
  • 6.2: Emerging Trends of Artificial Intelligence in the Global Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of Artificial Intelligence in the Global Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures of Artificial Intelligence in the Global Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: Siemens
  • 7.3: Aidoc Medical
  • 7.4: AliveCor
  • 7.5: Imagen Technologies
  • 7.6: VUNO
  • 7.7: IDx Technologies
  • 7.8: NovaSignal Corporation
  • 7.9: Riverain Technologies
  • 7.10: Zebra Medical Vision